Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:30 pm Sale |
2024-12-31 | 13G | Amylyx Pharmaceuticals, Inc. AMLX |
Panacea Venture Healthcare Fund II, L.P. | 2,200,000 2.600% |
-2,000,000 (-47.62%) |
Filing History |
| 2025-02-14 4:15 pm Purchase |
2024-12-31 | 13G | Amylyx Pharmaceuticals, Inc. AMLX |
PERCEPTIVE ADVISORS LLC | 6,774,348 7.900% |
2,315,607 (+51.93%) |
Filing History |
| 2025-01-14 4:53 pm Purchase |
2025-01-13 | 13G | Amylyx Pharmaceuticals, Inc. AMLX |
Point72 Asset Management, L.P. | 4,820,333 5.600% |
1,617,952 (+50.52%) |
Filing History |
| 2024-11-12 1:22 pm Unchanged |
2024-09-30 | 13G | Amylyx Pharmaceuticals, Inc. AMLX |
The Vanguard Group | 3,089,645 4.530% |
0 (Unchanged) |
Filing History |
| 2024-11-04 10:56 am Sale |
2024-09-30 | 13G | Amylyx Pharmaceuticals, Inc. AMLX |
The Vanguard Group | 3,089,645 4.530% |
-2,185,921 (-41.43%) |
Filing History |
| 2024-10-25 5:38 pm Purchase |
2024-10-18 | 13G | Amylyx Pharmaceuticals, Inc. AMLX |
PERCEPTIVE ADVISORS LLC | 4,458,741 6.500% |
2,589,616 (+138.55%) |
Filing History |
| 2024-08-26 6:49 pm Purchase |
2024-08-14 | 13G | Amylyx Pharmaceuticals, Inc. AMLX |
TCG Crossover GP II, LLC | 4,643,812 6.800% |
4,643,812 (New Position) |
Filing History |
| 2024-07-08 4:32 pm Sale |
2024-06-30 | 13G | Amylyx Pharmaceuticals, Inc. AMLX |
BLACKROCK INC BLK |
2,669,741 3.900% |
-1,332,593 (-33.30%) |
Filing History |
| 2024-03-11 08:44 am Purchase |
2024-03-08 | 13G | Amylyx Pharmaceuticals, Inc. AMLX |
Panacea Venture Healthcare Fund II, L.P. | 4,200,000 6.200% |
4,200,000 (New Position) |
Filing History |
| 2024-02-14 4:36 pm Sale |
2023-12-31 | 13G | Amylyx Pharmaceuticals, Inc. AMLX |
PERCEPTIVE ADVISORS LLC | 1,869,125 2.800% |
-4,219,208 (-69.30%) |
Filing History |
| 2024-02-14 10:24 am Sale |
2023-12-31 | 13G | Amylyx Pharmaceuticals, Inc. AMLX |
VIKING GLOBAL INVESTORS LP | 2,962,555 4.400% |
-1,672,051 (-36.08%) |
Filing History |
| 2024-02-14 07:15 am Sale |
2023-12-31 | 13G | Amylyx Pharmaceuticals, Inc. AMLX |
Point72 Asset Management, L.P. | 3,202,381 4.700% |
-268,310 (-7.73%) |
Filing History |
| 2024-02-13 4:58 pm Purchase |
2023-12-29 | 13G | Amylyx Pharmaceuticals, Inc. AMLX |
The Vanguard Group | 5,275,566 7.810% |
917,074 (+21.04%) |
Filing History |
| 2024-01-29 5:25 pm Purchase |
2023-12-31 | 13G | Amylyx Pharmaceuticals, Inc. AMLX |
BLACKROCK INC BLK |
4,002,334 5.900% |
385,408 (+10.66%) |
Filing History |
| 2023-12-11 4:15 pm Purchase |
2023-11-29 | 13G | Amylyx Pharmaceuticals, Inc. AMLX |
Point72 Asset Management, L.P. | 3,470,691 5.100% |
3,470,691 (New Position) |
Filing History |
| 2023-10-04 4:19 pm Sale |
2023-09-25 | 13D | Amylyx Pharmaceuticals, Inc. AMLX |
Morningside Venture Investments Limited | 2,313,227 3.430% |
-2,305,619 (-49.92%) |
Filing History |
| 2023-08-17 5:15 pm Sale |
2023-08-15 | 13D | Amylyx Pharmaceuticals, Inc. AMLX |
Morningside Venture Investments Limited | 4,618,846 6.860% |
-4,000,000 (-46.41%) |
Filing History |
| 2023-06-09 3:54 pm Purchase |
2023-05-30 | 13G | Amylyx Pharmaceuticals, Inc. AMLX |
GOLDMAN SACHS GROUP INC GS |
3,653,782 5.400% |
3,653,782 (New Position) |
Filing History |
| 2023-04-03 4:43 pm Sale |
2023-03-29 | 13D | Amylyx Pharmaceuticals, Inc. AMLX |
Morningside Venture Investments Limited | 8,618,846 12.920% |
-683,296 (-7.35%) |
Filing History |
| 2023-02-14 2:33 pm Purchase |
2022-12-31 | 13G | Amylyx Pharmaceuticals, Inc. AMLX |
PERCEPTIVE ADVISORS LLC | 6,088,333 9.200% |
3,116,920 (+104.90%) |
Filing History |